Eliem Therapeutics Statistics Share Statistics Eliem Therapeutics has 67.06M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 67.06M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 99.99% Shares Floating 26.24M Failed to Deliver (FTD) Shares 48,972 FTD / Avg. Volume 9.42%
Short Selling Information The latest short interest is 3.33M, so 0% of the outstanding
shares have been sold short.
Short Interest 3.33M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.2
Valuation Ratios The PE ratio is -2.68 and the forward
PE ratio is -7.41.
Eliem Therapeutics's PEG ratio is
-0.15.
PE Ratio -2.68 Forward PE -7.41 PS Ratio 0 Forward PS n/a PB Ratio 0.93 P/FCF Ratio -12.72 PEG Ratio -0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Eliem Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 31.41,
with a Debt / Equity ratio of 0.
Current Ratio 31.41 Quick Ratio 31.41 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-8.21M Employee Count 9 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -14.69% in the
last 52 weeks. The beta is -0.38, so Eliem Therapeutics's
price volatility has been lower than the market average.
Beta -0.38 52-Week Price Change -14.69% 50-Day Moving Average 6.13 200-Day Moving Average 5.58 Relative Strength Index (RSI) 25.78 Average Volume (20 Days) 519,722
Income Statement
Revenue n/a Gross Profit n/a Operating Income -82.02M Net Income -73.9M EBITDA -82.02M EBIT n/a Earnings Per Share (EPS) -1.53
Full Income Statement Balance Sheet The company has 87.23M in cash and 532K in
debt, giving a net cash position of 86.7M.
Cash & Cash Equivalents 87.23M Total Debt 532K Net Cash 86.7M Retained Earnings -229.88M Total Assets 200.74M Working Capital 93.24M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -15.56M
and capital expenditures 0, giving a free cash flow of -15.56M.
Operating Cash Flow -15.56M Capital Expenditures n/a Free Cash Flow -15.56M FCF Per Share -0.32
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
